StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Eli Lilly (LLY) PT Raised to $957 at Jefferies
June 6, 2024 4:27 PM
Jefferies analyst Akash Tewari raised the price target on Eli Lilly (NYSE: LLY) to $957.00 (from $925.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Form 4 ELI LILLY & Co For: Jun 05 Filed by: LILLY ENDOWMENT INC
June 6, 2024 4:00 PM
US FDA staff raise no major concerns about Eli Lilly Alzheimer's drug
June 6, 2024 9:59 AM
Eli Lilly & Co. (LLY) on Watch After FDA Posts Documents Ahead of Panel Meeting for AD Drug
June 6, 2024 9:18 AM
Shares in Wegovy-maker Novo Nordisk climb, touching record high levels
June 6, 2024 6:25 AM
Form 144 ELI LILLY & Co Filed by: LILLY ENDOWMENT INC
June 5, 2024 2:23 PM
Alphabet names Eli Lilly's Ashkenazi as its new CFO
June 5, 2024 8:35 AM
Alphabet (GOOGL): Anat Ashkenazi to Join Google and Alphabet as Chief Financial Officer
June 5, 2024 7:57 AM
Alphabet names Lilly executive Anat Ashkenazi as CFO
June 5, 2024 7:56 AM
Form 8-K ELI LILLY & Co For: Jun 02
June 5, 2024 7:48 AM
Eli Lilly & Co. (LLY) announces departure of Anat Ashkenazi, chief financial officer
June 5, 2024 7:45 AM
Lilly announces departure of Anat Ashkenazi, chief financial officer
June 5, 2024 7:45 AM
Form 4 ELI LILLY & Co For: Jun 01 Filed by: Rau Diogo
June 4, 2024 4:14 PM
Form 4 ELI LILLY & Co For: Jun 03 Filed by: LILLY ENDOWMENT INC
June 4, 2024 4:00 PM
